One needs to look no further than today’s pharma industry to prove that “necessity is the mother of invention.” Acute challenges swamping th...

Over the last month China pharma issues have been on the front page as the government has launched a wide-ranging probe focused on complia...

Recently there’s been a more positive outlook on the industry from some sectors of Wall Street built on conviction that pharma has r...

Our colleagues at PharmAsia News are launching a survey on the China life sciences industry. We encourage all readers interested in Ch...

Investors gauging the market mood look for signs. We also spent two days this week at the BioInvestor Forum in San Francisco looking for sig...

MedtechWOMEN co-founders Amy Belt and Deborah Kilpatrick Something new happened in the medical device world two weeks ago. It wasn'...

You may have heard of the Chinese business concept of guanxi , but do you really understand it? The term, loosely defined as "relations...

The annual January health care confab in San Francisco is ostensibly run by JPMorgan but long ago took on a life of its own and spread well ...

The liver disease community – if not the investment community – has largely moved on from the novelty of comparing Vertex Pharmaceuticals...